Publikationsliste

Alle Publikationen sind mit dem Entrez-Pubmed verlinkt. Dort finden Sie auch die vollständige Liste aller Publikationen.

 
Gil-Bea FJ, Gerenu G, Aisa B, Kirazov LP, Schliebs R, Ramírez MJ
Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice.
Neurobiol Dis. 2012 Jul 1. [Epub ahead of print]
 
F. Kara F, E.S. van Dongen, R. Schliebs, M.A. van Buchem, H.J.M. de Groot and A. Alia
Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by Magnetic Resonance Angiography at 17.6 T.
NeuroImage 60 (2012) 958 - 966.
 
Kasabov N, Schliebs R, Kojima H
Probabilistic computational neurogenetic modeling: from cognitive systems to Alzheimer’s disease.
IEEE Trans Autonom Mental Dev 3 (2011) 300-311.
 
Zarazúa S, Bürger S, Delgado JM, Jimenez-Capdeville ME, Schliebs R
Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of APP.
Int J Dev Neurosci 29 (2011) 389-396.
 
M. Hartlage-Rübsamen, A. Waniek, C. Jäger, U. Zeitschel, B. Koch, H. Cynis, S. Schilling, R. Schliebs, H.-U. Demuth, M. Morawski, S. Roßner
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Abeta deposits in hippocampus via distinct cellular mechanisms.
Acta Neuropathol. 121 (2011) 705-719.
 
Hawkes CA, Härtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.
Acta Neuropathol. 121 (2011) 431-443
 
Schliebs R, Arendt T
The cholinergic system in aging and neuronal degeneration.
Behav Brain Res. 221 (2011) 555-563.
 
Ihunwo A.O., Schliebs R.
Cell proliferation and total granule cell number in dentate gyrus of transgenic Tg2576 mouse
Acta Neurobiol Exp (Wars) 70 (2010) 362-369.
 
S. Bürger, Y. Yafai, M. Bigl, P. Wiedemann, R. Schliebs
Effect of VEGF and its receptor antagonist SU-5416, an inhibitor of angiogenesis, on processing of the beta-amyloid precursor protein in primary neuronal cells derived from brain tissue of Tg2576 mice.
Int J Dev Neurosci. 28 (2010) 597-604.
 
F. Kara, N. Braakman, M.A. van Buchem, H.J. de Groot, R. Schliebs, A. Alia
In vivo longitudinal monitoring of blood flow alterations in Tg2576 mouse model of Alzheimer’s disease.
Proc. Int. Soc. Magn. Reson. Med. 18 (2010) 4273.
 
R Schliebs
Molecular mechanisms of cholinergic dysfunction in Alzheimer’s disease – cell culture and animal approches. In: Tópicos de Actuación en Neurobilogía: Biología molecular del desarollo, neurodegeneración y medicina genómica (Eds., Daniel Ortuño Sahagún, Carlos Beas Zarate, Juan Armendáriz, Mercè Pallàs Lliberia, Antoni Camins)
Universidad de Guadalajara, 2010, pp. 129-146. (ISBN 978-970-764-867-8)
 
C.K. Donat, R. Bauer, T. Kayser, B. Walter, T. Kayser, R. Schliebs, W. Deuther-Conrad, K. Nieber, W. Härtig, P. Brust
Effects of lateral fluid percussion injury on cholinergic markers in the newborn piglet brain.
Int J Dev Neurosci 28 (2010) 31-38.
 
S. Ebert, M. Goos, L. Rollwagen, D. Baake, W.-D. Zech, H. Esselmann, J. Wiltfang, M.L. Kramer, B. Mollenhauer, R. Schliebs, J. Gerber, R. Nau
Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
J Neurosci. Res. 88 (2010) 1124-1136.
 
K. Plaschke, J. Kopitz, M. Siegelin, R. Schliebs, M. Salko-Petricic, P. Riederer, S. Hoyer
Insulin-resistant brain state after intracerebroventricular streptozotocin injection deteriorates Alzheimer-like changes in tg2576 APP-overexpressing mice.
J. Alzheimer Dis. 19 (2010) 691-704.
 
G. Glavan, R. Schliebs, M. Zivin
Synaptotagmins in neurodegeneration.
The Anatomical Record 292 (2009) 1849-1862.
 
Beas Zarate C, Gudiño Cabrera G, Armendariz Boruranda J, Schliebs R
Terapia génica en enfermedades neurodegenerativas. In: BIOLOGIA MOLECULAR: Fundamentos y aplicaciones (Eds., Carlos Beas Zarate, Daniel Ortuño Sahagún, Juan Armendariz-Borunda);
McGraw Hill, Mexico City, 2009, pp. 130-142. (ISBN 13: 978-970-10-6921-9).
 
N. Braakman, M. van Buchem, R. Schliebs, H.J.M. de Groot, A. Alia
Recent advances in visualizing Alzheimer´s plaques by in vivo magnetic resonance imaging.
Current Medical Imaging Reviews 5 (2009) 2-9.
 
Bürger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E, Yafai Y, Schliebs R
Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain
Int J Dev Neurosci 27 (2009) 517-523.
 
Walther T, Albrecht D, Becker M, Schubert M, Kouznetsova E, Wiesner, B., Maul, B., Schliebs, R., Grecksch, G., Furkert, J., Sterner-Kock, A., Schultheiss, H.-P., Becker, A., Siems W.-E.
Improved Learning and Memory in Aged Mice Deficient in Amyloid beta-Degrading Neutral Endopeptidase
PLoS ONE 4(2): e4590. doi:10.1371/journal.pone.0004590
 
Sorger D, Scheunemann M, Vercouillie J, Großmann U, Fischer S, Hiller A, Wenzel B, Roghani A, Schliebs R, Steinbach J, Brust P, Sabri O.
Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]Fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines.
Nucl Med Biol 36 (2009) 17-27.
 
Augustin S, Rimbach G, Augustin K, Schliebs R, Wolffram S, Cermak R.
Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
Arch Biochem Biophys 481 (2009) 177-182
 
Rivera-Cervantes MC, Flores-Soto ME, Chaparro-Huerta, Reyes-Gómez J, Feria-Velasco A, Schliebs R, Beas-Zárate C
Changes in hippocampal NMDA-R subunit composition induced by exposure of neonatal rats to L-glutamate.
Int J Devl. Neurosci 27 (2009) 197-204
 
Morawski M, Pavlica S, Seeger G, Grosche J, Kouznetsova E, Schliebs R, Brückner
Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice.
Neurobiol. Aging 2008, in press. [Epub ahead of print]
 
Bigl K, Gaunitz F, Schmitt A, Rothemund S, Schliebs R, Münch G, Arendt T
Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation.
J Neural Transm 115 (2009) 1545-1556
 
Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, Burwinkel M, Schliebs R
Prion infection of mice transgenic for human APPSwe: Increased accumulation of cortical fibrillar Abeta(1-42) and rapid scrapie disease development.
Int J Dev Neurosci 26 (2008) 821-824.
 
Fiedorowicz A, Figiel I, Zaremba M, Dzwonek K, Schliebs R, Oderfeld-Nowak B
Trimethyltin–evoked apoptosis of murine hippocampal granule neurons is accompanied by the expression of interleukin-1beta and interleukin-1 receptor antagonist in the cells of ameboid phenotype, the majority of which are NG2-positive.
Brain Res Bull 77 (2008) 19-26.
 
Augustin S, Huebbe P, Matzner N, Augustin K, Schliebs R, Cermak R, Wolffram S, Rimbach G
Ginkgo biloba extract and its flavonol and terpenelacton fractions do not affect beta-secretase mRNA and enzyme activity levels in cultured neurons and in laboratory mice.
Planta Medica 74 (2008) 6-13.
 
Joerchel S, Raap M, Bigl M, Eschrich K, Schliebs R
Oligomeric beta-amyloid(1-42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis.
Int. J Dev. Neurosci. 26 (2008) 301-308
 
Herrmann P, Druckrey-Fiskaaen C, Kouznetsova E, Heinitz K, Bigl M, Cotman SL, Schliebs R
Developmental impairments of select neurotransmitter systems in brains of Cln3deltaex7/8-knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
J. Neurosci. Res. 86 (2008) 1857-1870.
 
Sorger D, Scheunemann M, Großmann U, Fischer S, Vercouille J, Hiller A, Wenzel B, Roghani A, Schliebs R, Brust P, Sabri O, Steinbach J
A new 18F-labelled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Nucl. Med. Biol. 35 (2008) 185-195.
 
Donat CK, Schuhmann MU, Voigt C, Nieber K, Schliebs R, Brust P:
Alterations of aetylcholinesterase aivity after traumatic brain injury in rats.
Brain Injury 21 (2007) 1031-1037.
 
Scheunemann M, Sorger D, Kouznetsova E, Sabri O, Schliebs R, Wenzel B, Steinbach J
Sequential ring-opening of trans-1,4-cyclohexadiene dioxide for an expedient modular approach to 6,7-disubstituted (+)-hexahydro-benzo[1,4]oxazin-3-ones.
Tetrahedron Lett. 48 (2007) 5497-5501.
 
Yun S-W, Kouznetsova E, Nitschke C; Heinitz K, Schliebs R, Gerlach M, Riederer P, Klein MA
Beta-amyloid deposition and prion infection in adult primary brain cell long-term culture model.
Biochem. Biophys. Res Commun. 360 (2007) 520-524.
 
Ihunwo AO, Luth H-J, Schliebs R, Kayanja FIB
Ultrastructural Features of Beta-Amyloid Plaques in Aged Transgenic Tg 2576 Mouse Brain with Alzheimer Plaque Pathology.
Res. J. Med. Sci. 1 (2007) 55-61.
 
Gil-Bea FJ, Aisa B, Schliebs R, Ramirez MJ.
Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice.
Behav Neurosci. 121 (2007) 340-344
 
Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O.
Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
Nucl Med Biol. 34 (2007) 331-342.
 
Stahl T, Reimers C, Johne R, Schliebs R, Seeger J.
Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
Eur J Neurosci. 24 (2006) 1923-1934.
 
Schliebs R, Arendt T.
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
J Neural Transm. 113 (2006) 1625-1644.
 
Sorger D, Becker G, Hauber K, Schildan A, Patt M, Birkenmeier G, Otto A, Meyer P, Kluge M, Schliebs R, Sabri O
Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]Fluoro-A-85380 to plasma proteins.
Nucl Med Biol 33 (2006) 899-906
 
Schliebs R, Heidel K, Apelt J, Gniezdzinska M, Kirazov L, Szutowicz A.
Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells.
Brain Res. 1122 (2006) 78-85.
 
N. Braakman, J. Matysik, S.G. van Duinen, F. Verbeek, R. Schliebs, H.J.M.de Groot, A. Alia
Longitudinal assessment of Alzheimer’s beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
J. Magn Reson Imaging 24 (2006) 530-536
 
M.E. Flores-Soto, M.E. Banuelos-Pineda, R. Schliebs, C. Beas-Zarate
Neuronal damage and changes in the expression muscarinic acetylcholine receptor subtypes in the neonatal rat cerebral cortex upon exposure to sparteine, a quinolizidine alkaloid
Int J Dev Neurosci 24 (2006) 401-410
 
K. Heinitz, M. Beck, R. Schliebs, J. R. Perez-Polo
Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells
J Neurochem. 98 (2006) 1930-1945.
 
Züchner T, Schliebe N, Schliebs R
Zinc uptake is mediated by M1 muscarinic acetylcholine receptors in differentiated SK-SH-SY5Y cells.
Int. J. Devl. Neurosci. 24 (2006) 23-27.
 
Schliebs R
Neural signal transduction in health and disease - cytokines, mitochondrial dysfunction and transport processes. Editorial.
Int J Dev Neurosci 24 (2006) 87-89.
 
Kouznetsova E, Klingner M, Sorger D, Sabri O, Großmann U, Steinbach J, Scheunemann M, Schliebs R
Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice.
Int J Dev Neurosci. 24 (2006) 187-193.
 
Liskowsky W, Schliebs R
Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein
Int J Dev Neurosci. 24 (2006) 149-156.
 
Wenzel B, Sorger D, Heinitz K, Scheunemann M, Schliebs R, Steinbach J, Sabri O
Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
Eur J Med Chem. 40 (2005) 1197-1205
 
Rossner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth HU.
Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer's Disease.
Neurochem Res. 30 (2005) 695-702.
 
T. Züchner, R. Schliebs, J.R. Perez-Polo
Downregulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer´s disease relevant genes and proteins.
J. Neurochem. 95 (2005) 20-32
 
R. Schliebs
Basal forebrain cholinergic dysfunction in Alzheimer´s disease – interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
Neurochem. Res. 30 (2005) 895-908.
 
L. Kirazov, E. Kirazov, R. Schliebs
L-Glutamate and phorbol ester stimulate the release of secretory amyloid precursor protein from rat cortical synaptosomes.
Acta Biol. Hung. 56 (2005) 177-183
 
R. Schliebs
Basal forebrain cholinergic lesion by 192IgG-saporin: a tool to assess the consequences of cortical cholinergic dysfunction in Alzheimer´s disease.
In: Molecular Neurosurgery with Targeted Toxins (R.G. Wiley and D.A. Lappi, Eds.), The Humana Press Inc., Totowa, NJ, 2005, pp. 59-86. ISBN: 1-58829-199-5
 
Schliebs R
Molecular mechanisms of neurodegeneration and neuroprotection - experimental approaches and the diseased brain. Editorial.
Int J Devl Neurosci 22 (2004) 441-442
 
Apelt J, Bigl M, Wunderlich P, Schliebs R
Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
Int J Devl Neurosci 22 (2004) 475-484
 
Zuchner T, Perez-Polo JR, Schliebs R
Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling
J Neurosci Res 77 (2004) 250-257
 
Scheunemann M, Sorger D, Wenzel B, Heinitz K, Schliebs R, Klingner M, Sabri O, Steinbach J
Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site
Bioorgan. Med. Chem. 12 (2004) 1459-1465
 
Blasko I, Beer R, Bigl M, Apelt J, Franz G, Rudzki D, Ransmayr G, Kampfl A, Schliebs R
Experimental traumatic brain injury in rat stimulates the expression, production and activity of Alzheimer’s disease beta-secretase(BACE-1)
J Neural Transm 111 (2004) 523-536.
 
Klingner M, Apelt J, Kumar A, Sorger D, Sabri O, Steinbach J, Scheunemann M, Schliebs R.
Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.
Int J Dev Neurosci 21 (2003) 357-369.
 
Münch G, Apelt J, Kientsch-Engel R, Stahl P, Lüth HJ, Schliebs R
Advanced glycation endproducts (AGEs) and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology
J Neurochem 86 (2003) 283-289
 
Lüth HJ, Apelt J, Ihunwo A, Schliebs R
Degeneration of beta-amyloid-associated cholinergic structures in transgenic APPsw mice
Brain Res 977 (2003) 16-22
 
Apelt J, Ach K, Schliebs R
Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques
Neurosci Lett 339 (2003) 183-186.
 
Hartlage-Rübsamen M, Zeitschel U, Apelt J, Gärtner U, Franke H, Stahl T, Günther A, Schliebs R, Penkowa M, Bigl V, Roßner S.
Astrocytic expression of the Alzheimer’s disease beta-secretase (BACE1)is stimulus-dependent.
Glia 41 (2003) 169-179.
 
Bigl M, Apelt J, Eschrich K, Schliebs R
Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
J Neural Transm 110 (2003) 77-94.
 
Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonzalez-Billault C, Maccioni RB.
AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576.
J. Alzheimers Dis. 4 (2002) 417-430.
 
Zeitschel U, Schliebs R, Rossner S, Bigl V, Eschrich K, Bigl M.
Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion.
J Neurochem 83 (2002) 371-380.
 
Apelt J, Kumar A, Schliebs R.
Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein
Brain Research 2002; 953:17-30.
 
Hartig W, Bauer A, Brauer K, Grosche J, Hortobagyi T, Penke B, Schliebs R, Harkany T.
Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?
Rev Neurosci. 2002;13(2):95-165
 
Loffler T, Lee SK, Noldner M, Chatterjee SS, Hoyer S, Schliebs R.
Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain.
J Neural Transm. 2001;108(12):1457-74.
 
Kirazov E, Kirazov L, Bigl V, Schliebs R.
Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo.
Int J Dev Neurosci 2001; 19:287-96
 
Rossner S, Apelt J, Schliebs R, Perez-Polo JR, Bigl V.
Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology.
J Neurosci Res. 2001; 64:437-46.
 
Loffler T, Al-Robaiy S, Bigl M, Eschrich K, Schliebs R.
Expression of fructose-1,6-bisphosphatase mRNA isoforms in normal and basal forebrain cholinergic lesioned rat brain.
Int J Dev Neurosci. 2001 Jun;19(3):279-85.
 
Schliebs R
Neuronal plasticity and degeneration.
Int J Dev Neurosci. 2001 Jun;19(3):229-30.
 
Rossner S, Mendla K, Schliebs R, Bigl V.
Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo.
Eur J Neurosci. 2001; 13:1644-1648.
 
Hartlage-Rubsamen M, Apelt J, Schliebs R.
Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology.
Neurosci Lett. 200; 302:73-76.
 
Hartlage-Rubsamen M, Schliebs R.
Sequential upregulation of cell adhesion molecules in degenerating rat basal forebrain cholinergic neurons and in phagocytotic microglial cells.
Brain Res 200; 897:20-26.
 
Apelt J, Schliebs R.
Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.
Brain Res 2001; 894:21-30.
 
Rossner S, Mehlhorn G, Schliebs R, Bigl V.
Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology.
Eur J Neurosci 2001; 13:269-278.
 
Hartlage-Rubsamen M, Schliebs R.
Rat basal forebrain cholinergic lesion affects neuronal nitric oxide synthase activity in hippocampal and neocortical target regions.
Brain Res 2001; 889:155-164.
 
Hoyer S, Lee SK, Loffler T, Schliebs R.
Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease?
Ann N Y Acad Sci 2000; 920:256-258.
 
Bigl M, Apelt J, Luschekina EA, Lange-Dohna C, Rossner S, Schliebs R.
Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology.
Neurosci Lett 2000; 292:107-110.
 
Rossner S, Beck M, Stahl T, Mendla K, Schliebs R, Bigl V.
Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation.
Eur J Neurosci 2000; 12:3191-3200.
 
Mehlhorn G, Hollborn M, Schliebs R.
Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
Int J Dev Neurosci 2000; 18:423-431.
 
Rossner S, Schliebs R, Bigl V.
Intracerebroventricular infusion of CHO5, a rat monoclonal antibody directed against mouse low-affinity nerve growth factor receptor (p75NTR), specifically labels basal forebrain cholinergic neurons in mouse brain.
Metab Brain Dis 2000; 15:17-27.
 
Sorger D, Schliebs R, Kampfer I, Rossner S, Heinicke J, Dannenberg C, Georgi P.
In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system.
Nucl Med Biol 2000; 27:23-31.
 
Reisner E, Noldner M, Rossner S, Chatterjee SS, Bigl V, Schliebs R.
Acute effect of KA-672, a putative cognitive enhancer, on neurotransmitter receptor binding in mouse brain.
Neurosci Lett 1999; 274:187-190.
 
Apelt J, Mehlhorn G, Schliebs R.
Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain.
J Neurosci Res 1999; 57:693-705.
 
Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V.
Regulated secretion of amyloid precursor protein by TrkA receptor stimulation in rat pheochromocytoma-12 cells is mitogen activated protein kinase sensitive.
Neurosci Lett 1999; 271:97-100.
 
Hartlage-Rubsamen M, Lemke R, Schliebs R.
Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection.
J Neurosci Res 1999; 57:388-398.
 
Lemke R, Hartlage-Rubsamen M, Schliebs R.
Differential injury-dependent glial expression of interleukins-1 alpha, beta, and interleukin-6 in rat brain.
Glia 1999; 27:75-87.
 
Lemke R, Rossner S, Schliebs R.
Leukemia inhibitory factor expression is not induced in activated microglia and reactive astrocytes in response to rat basal forebrain cholinergic lesion.
Neurosci Lett 1999; 267:53-56.
 
Sorger D, Kampfer I, Schliebs R, Rossner S, Dannenberg C, Knapp WH.
Iodo-QNB cortical binding and brain perfusion: effects of a cholinergic basal forebrain lesion in the rat.
Nucl Med Biol 1999; 26:9-16.
 
Stahl T, Goldammer A, Luschekina E, Beck M, Schliebs R, Bigl V.
Long-term basal forebrain cholinergic-rich grafts derived from trisomy 16 mice do not develop beta-amyloid pathology and neurodegeneration but demonstrate neuroinflammatory responses.
Int J Dev Neurosci 1998; 16:763-775.
 
Mehlhorn G, Loffler T, Apelt J, Rossner S, Urabe T, Hattori N, Nagamatsu S, Bigl V, Schliebs R.
Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion.
Int J Dev Neurosci 1998; 16:675-690.
 
Rossner S, Bakinde N, Zeitschel U, Schliebs R, Bigl V.
Cerebrospinal fluid cholinesterases--markers for loss of cholinergic basal forebrain neurons?
Int J Dev Neurosci 1998; 16:669-673.
 
Schliebs R.
Basal forebrain cholinergic dysfunction-experimental approaches and the diseased brain.
Int J Dev Neurosci 1998; 16:591-593.
 
Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V.
Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells.
J Neural Transm Suppl 1998; 54:279-285.